Shahidi S

No ORCID on file · 10 papers in corpus · active 2017-2021
2021
Metabolic brain disease ·doi:10.1007/s11011-021-00713-8

Alzheimer's disease is the most common neurodegenerative disease associated with deposition of amyloid-beta and the increased oxidative stress. High free radical scavenging ability of selenium nanoparticles (SeNPs) has been acknowledged, so…

2021
The international journal of biochemistry & cell biology ·doi:10.1016/j.biocel.2021.106089

Alzheimer's disease (AD) is one of the common neurodegenerative diseases characterized by memory impairment. The protective effects of stem cell-based therapy have been reported in AD. In this study, it was assumed that Chitosan-coated Sele…

2021
Life sciences ·doi:10.1016/j.lfs.2021.120093

AimsStem cell-based therapy is one of the promising strategies in the treatment of Alzheimer's disease (AD), but the short lifespan and low homing of transplanted cells continue to be a major obstacle in this method. Preconditioning of stem…

2021
Life sciences ·doi:10.1016/j.lfs.2021.119246

AimsMemory impairment is determined to be the most well-known symptom of Alzheimer's disease (AD). Although cell therapy seems is an efficient therapeutic strategy to attenuate the AD-related memory impairment, transplanted cells have a sho…

2020
Metabolic brain disease ·doi:10.1007/s11011-019-00529-7

Regulatory role of vitamin D (VitD) in cognitive memory and learning has been proposed. Here, we examine the behavioral and biochemical effects of VitD in Alzheimer's disease (AD), as the most common form of dementia, in male Wistar rats. A…

2020
Life sciences ·doi:10.1016/j.lfs.2020.117482

AimsImproving the environment of the injured area and the preconditioning of mesenchymal stem cells (MSCs) are promising approaches to optimize the therapeutic properties of transplanted MSCs. Herein we investigated the synergistic effects …

2019
Physiology & behavior ·doi:10.1016/j.physbeh.2018.11.034

Mesenchymal stem cell (MSC) transplantation therapy has been proposed as a promising approach for the treatment of neurodegenerative disease. Chemical and pharmacological preconditioning before transplantation could optimize the therapeutic…

2017
Metabolic brain disease ·doi:10.1007/s11011-017-0114-1

In the original publication of the article, author name Masoumeh Asadbegi was incorrectly written as Masoumeh Asadbeigi. The authors regret the oversight.

2017
Metabolic brain disease ·doi:10.1007/s11011-017-0046-9

3, 4-methylenedioxymethamphetamine (MDMA) or ecstasy is a derivative of amphetamine that leads to long term potentiation (LTP) disruption in the hippocampal dentate gyrus (DG). Exercise has been accepted as a treatment for the improvement o…

2017
Journal of neuroscience research ·doi:10.1002/jnr.24078

3,4-methylenedioxymethamphetamine (MDMA) leads to apoptosis in the hippocampus with consequent induction of learning and memory impairment. In this study, we have investigated the effects of treadmill exercise on memory in relation to apopt…